ORGS
Orgenesis Inc.Company with tickers: ORGS
CIK
1460602
Shares Outstanding
9,799,538
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $530,000 | USD | 2023-12-31 | 10-K | 2026-03-26 |
| Cost of Revenue | $6,255,000 | USD | 2023-12-31 | 10-K | 2026-03-26 |
| Gross Profit | $-5,725,000 | USD | 2023-12-31 | 10-K | 2026-03-26 |
| Operating Expenses | — | ||||
| Research & Development | $10,623,000 | USD | 2023-12-31 | 10-K | 2026-03-26 |
| Operating Income | $-53,636,000 | USD | 2023-12-31 | 10-K | 2026-03-26 |
| Net Income | $-55,361,000 | USD | 2023-12-31 | 10-K | 2026-03-26 |
| EPS (Basic) | $19.08 | USD/shares | 2023-12-31 | 10-K | 2026-03-26 |
| EPS (Diluted) | $19.08 | USD/shares | 2023-12-31 | 10-K | 2026-03-26 |